Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Comparative Sensitivity of FDG-PET/CT and Contrasted CT in Identifying Biopsy Targets in Neurosarcoidosis

Author:Morehead, Adam   Roy-Hewitson, Chantal   

Session Name:P3: Autoimmune Neurology: Inflammatory NOS 1  

Topic:Autoimmune Neurology  

Program Number:P3.009  

Author Institution:The University of Vermont Medical Center, Burlington, VT  University of Vermont Medical Center, Burlington, VT  

Opakalim (BHV-7000) Potentiates the Activity of Kv7.2/7.3 Channels Containing a Single Copy of the Kv7.2 DEE-Causing Mutation, G281E

Author:Spitznagel, Brittany   Komarov, Alexander   DeMarco, Ulrike   Smith, Kelly   Wang, Ling-Xin   Resnick, Lynn   Picchione, Kelly   Lerner, Jason   Weaver, David   Dworetzky, Steven   Bozik, Michael   

Session Name:P3: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Mechanisms and Pharmacology  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P3.009  

Author Institution:Biohaven Pharmaceuticals, CT  Biohaven Pharmaceuticals, Pittsburgh, PA  Biohaven Pharmaceuticals, New Haven, CT  

Successful Treatment of Refractory Gastroparesis-related Nausea in Parkinson’s Disease with Mirtazapine

Author:Orozco, Emma   Sugar, Dana   

Session Name:P3: Movement Disorders: Parkinson's Disease Management 1  

Topic:Movement Disorders  

Program Number:P3.009  

Author Institution:University of New Mexico, Albuquerque, NM  

Bridging the Gap: Engaging Non-traditional Research Sites to Increase Participation in Multiple Sclerosis Clinical Research

Author:Wolf, Andrew   Bosque, Patrick   Sillau, Stefan   Kielty, Tatiana   adkisson, isabel   valdez, carolyn   Engebretson, Eric   geyer, melissa   Lublin, Alex   Chavin, jeffrey   Nair, Kavita   

Session Name:P3: Multiple Sclerosis: Health Care Disparities and Opportunities 1  

Topic:Multiple Sclerosis  

Program Number:P3.009  

Author Institution:University of Colorado Anschutz Medical Campus, Aurora, CO  Denver Health Medical Center, Denver, CO  University of Colorado Denver, Aurora, CO  Sanofi Genzyme, Concord, MA  University of Colorado, Aurora, CO  

Tocilizumab as Add-on Therapy for Severe Attacks in NMOSD and MOGAD: A Multicenter Retrospective Case Series

Author:Flanagan, Eoin P.   Vilaseca, Andreu   Bilodeau, Philippe-Antoine   Filippatou, Angeliki G.   Jiang, Mulan   Said, Yana   Chen, Haiwen   Chen, John J.   Pittock, Sean J.   Sotirchos, Elias   Levy, Michael   Kister, Ilya   

Session Name:P3: Autoimmune Neurology: NMOSD/MOGAD 3  

Topic:Autoimmune Neurology  

Program Number:P3.009  

Author Institution:Department of Neurology and Center for MS and Autoimmune Neurology, Mayo Clinic College of Medicine, USA, Rochester, MN  Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA  Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA, Baltimore, MD  Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Cambridge, MA  Department of Neurology, New York University Langone Medical Centre, New York, NY, USA, New York, NY